Load Dependent Modulation of Spinal Excitability: Linking H-Reflex Supression and Whole Body Vibration Induced Reflex Latency (SRML)

March 23, 2026 updated by: İsmet Alkım Özkan, Istanbul Physical Medicine Rehabilitation Training and Research Hospital
This study examines how different standing postures and whole-body vibration conditions affect spinal reflex activity. Participants will stand in various positions-with and without vibration of two amplitudes-and H-reflex responses from the soleus muscle will be recorded. Additionally, vibration-induced reflex latency will be assessed across multiple vibration frequencies.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Participants will engage in a structured set of experimental tasks designed to evaluate the effects of postural mechanical loading, and whole-body vibration.

The protocol includes four primary standing conditions:

Quiet bipedal stance,

Single-leg stance on the left side,

Bipedal stance during whole-body vibration (WBV), and

Single-leg stance on the left side during WBV.

During all WBV conditions, two vibration amplitudes-2.2 mm and 1.2 mm-will be applied sequentially to assess amplitude-dependent modulation of reflex responses.

Throughout each condition, H-reflex recordings from the soleus muscle will be collected to quantify changes in spinal reflex excitability under varying postural and vibratory loads. In addition to these measurements, vibration-induced reflex latency will be evaluated by delivering vibratory stimuli at multiple frequencies (30, 32, 34, and 36 Hz) within the same experimental protocol. This approach allows for a comprehensive analysis of how both posture and vibratory parameters influence neuromuscular reflex pathways.

The investigators conducted an a priori power analysis for a repeated-measures ANOVA (within-subjects design) to determine the required sample size. The analysis was based on a medium expected effect size, specified as partial eta squared (ηₚ²) = 0.06, which corresponds to an effect size of f = 0.25. The investigators set the alpha error probability at 0.05 and the desired statistical power (1-β) at 0.80. The design included one group with five repeated measurements, assuming a correlation of 0.70 among repeated measures. Under these conditions, the critical F value was 2.5652405, with 4 numerator degrees of freedom and 48 denominator degrees of freedom. The power analysis indicated that a total sample size of 13 participants is required. The required sample size was calculated using G*Power version 3.1.9.4 (Franz Faul, University of Kiel, Germany).

Study Type

Interventional

Enrollment (Actual)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Bahçelievler
      • Istanbul, Bahçelievler, Turkey (Türkiye), 34158
        • Istanbul Physical Medicine Rehabilitation Training and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Healthy adults between 25 and 50 years of age
  • Individuals willing to participate and able to provide informed consent
  • Individuals who can stand independently for at least 10 minutes
  • Participants with no known neurological, orthopedic, or balance impairments

Exclusion Criteria:

  • Individuals who can not tolerate WBV
  • Individuals who can not tolerate electrical stimulation
  • Pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Healthy participants
Participants will complete a series of experimental tasks involving postural mechanical and vibrational loading. The protocol consists of quiet standing on both feet, single-leg standing on the left side, standing during whole-body vibration (WBV), and single-leg standing on the left side during WBV. Vibration amplitudes of 2.2 mm and 1.2 mm will be applied in each condition. H-reflex measurements will be recorded from the soleus muscle throughout all tasks to evaluate alterations in spinal reflex excitability. Vibration induced reflex latency will be also measured with different vibration frequencies (30-32-34-36) also measured in the same protocol.
Whole Body Vibration (WBV) is a neuromuscular training modality in which patients stand, sit, or exercise on a platform that delivers mechanical oscillations (30-36 Hz, 1-2 mm amplitude). While WBV is applied H-Reflex tests are done.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Whole Body Vibration induced reflex latency
Time Frame: Day 1 (single-session, during each experimental condition)
WBV induced reflex latency will be measured
Day 1 (single-session, during each experimental condition)
H-Reflex Size
Time Frame: Day 1 (single-session, during each experimental condition)
Peak to peak amplitude of the H-Reflex will be measured
Day 1 (single-session, during each experimental condition)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 21, 2025

Primary Completion (Actual)

December 8, 2025

Study Completion (Actual)

December 30, 2025

Study Registration Dates

First Submitted

November 19, 2025

First Submitted That Met QC Criteria

November 19, 2025

First Posted (Actual)

November 28, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2026

Last Update Submitted That Met QC Criteria

March 23, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • IstPRMTRH2A

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Vibration

Clinical Trials on Whole Body Vibration

Subscribe